ASH 2019
American Society of Hematology Annual Meeting
Interviews and expert commentary from ASH 2019 — study authors and key opinion leaders discuss the findings and their clinical implications.
New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia
Audio Journal of Oncology SAN DIEGO—The first-line treatment of choice for older patients with chronic lymphocytic leukemia (CLL) should now be single agent ibrutinib according to conclu
Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation
Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation The Audio Journal of Oncology Podcast SAN DIEGO—Overall survival after allogeneic hematopoietic cell transplant
Genomic-led AML Clinical Decision Making Within Seven Days
The “Beat AML” study assesses an algorithm screening for genomic features in order to choose appropriate targeted therapies for individual patients with their specific form of AML